Welcome to our dedicated page for Transcat SEC filings (Ticker: TRNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Transcat Inc (Nasdaq: TRNS), a provider of accredited calibration services, cost control and optimization services, and distribution and rental of professional grade handheld test, measurement, and control instrumentation. These regulatory documents offer detailed insight into Transcat’s operations, governance, and financial condition.
Through its periodic reports such as the Form 10-K and Form 10-Q (not reproduced here), Transcat describes its two operating segments—Service and Distribution—its focus on highly regulated industries including Life Science, aerospace and defense, energy and utilities, and industrial manufacturing, and the risks and opportunities associated with its calibration and distribution activities.
Current reports on Form 8-K are particularly relevant for tracking material events. Recent 8-K filings have disclosed the completion of the Essco Calibration Laboratory acquisition, entry into a new five-year $150 million secured revolving credit facility, quarterly earnings releases, executive leadership changes, and a CEO transition agreement. Other 8-Ks detail equity retention awards for certain executive officers and the appointment or retirement of key finance and board personnel.
Transcat’s proxy statement on Form DEF 14A outlines its board structure, committee composition, Corporate Governance Guidelines, executive compensation programs, and matters submitted to shareholder votes, such as director elections, say-on-pay, and auditor ratification. The proxy materials also summarize the company’s description of its business and strategic priorities, including its acquisition strategy.
On Stock Titan, investors can use AI-powered tools to quickly interpret these filings, with summaries that highlight items such as segment definitions, acquisition terms, credit facility covenants, and compensation arrangements. Filings related to executive equity awards, succession planning, and shareholder meeting results are especially useful for understanding how Transcat’s governance and capital allocation decisions may relate to TRNS stock.
Transcat, Inc. (TRNS) reporting person Cynthia Langston, a director, recorded equity award activity on Form 4. On 09/11/2025 Ms. Langston was reported to have acquired 704 shares through vesting or conversion of restricted stock units at $0 per share and continues to beneficially own 1,837 shares of common stock directly after the reported transactions. A prior grant of 1,587 RSUs (granted 09/10/2025) was noted as exempt under Rule 16b-3 and generally vests on 09/10/2026, while 1,587 RSUs vested on 09/10/2025 and converted one-for-one into common shares. Additionally, a stock option covering 10,000 shares with an exercise price of $73.80 and a five-year pro rata vesting schedule was reported.
Kristina L. Johnston, Principal Accounting Officer of Transcat, Inc. (TRNS), reports beneficial ownership of 358 restricted stock units (RSUs) awarded under the Transcat, Inc. 2021 Stock Incentive Plan. Each RSU converts into one share of common stock on a one-for-one basis and, unless noted otherwise in the award, vests on March 25, 2028. The statement indicates direct ownership of these RSUs.
Transcat, Inc. reported that effective September 10, 2025, Kristina Johnston, age 48, was appointed as principal accounting officer, following the planned retirement of prior principal accounting officer Scott D. Deverell. She has served as the Company’s controller since June 2025 and previously was Chief Financial Officer of Vintage Wine Estates, Inc. from March 2022 to December 2025 and held finance leadership roles at Constellation Brands, Inc. from 2018 to 2022.
Johnston’s annual base salary will be $250,000, with a target performance-based cash incentive of 30% of base salary and a target long-term equity incentive opportunity of 25% of base salary, plus participation in standard benefits. At the September 10, 2025 annual meeting, shareholders re-elected three directors with over 7.7 million votes each, approved executive compensation, and indicated a preference for holding advisory votes on executive pay every 1 year, which the Board adopted, with the next frequency vote to occur no later than the 2031 annual meeting.
Transcat Inc (TRNS) filed a Form 144 notifying the market of a proposed sale of 10,000 common shares with an aggregate market value of $821,200. The sale is to be executed approximately on 08/26/2025 on Nasdaq. The filing shows the seller acquired underlying shares through a direct purchase (324 shares purchased for cash on 11/05/2012) and vested restricted stock units (50,946 shares vested on 08/20/2019 as equity compensation). The issuer has 9,319,079 shares outstanding per the form. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Lee D. Rudow, President, CEO and Director of Transcat, Inc. (TRNS), reported multiple equity transactions dated 08/21/2025. The filing shows a disposition of 93,864 shares of Transcat common stock and the grant of several restricted stock unit (RSU) awards that convert one-for-one into common shares: 14,782, 12,500, 3,925, and 8,785 RSUs. Specific vesting schedules are provided for each award, with portions vesting on March 28, 2026, March 27, 2027, and March 25, 2028 as noted.
In addition, a stock option covering 10,000 shares with an exercise price of $63.17 is reported as fully exercisable as of the report date. The report was signed by an attorney-in-fact on behalf of Mr. Rudow on 08/25/2025. The RSU grants are identified as issued under the Transcat, Inc. 2021 Stock Incentive Plan and are described as transactions exempt under Rule 16b-3.
Transcat, Inc. entered into a Transition Agreement with President and CEO Lee D. Rudow to manage his planned retirement and move into an advisory role. Effective March 30, 2025, he will receive a base salary of $741,000 per year, a target bonus of up to 100% of that salary for fiscal 2026, and equity incentive awards with a target value of $2.5 million. He also received 12,500 time-based restricted stock units and 12,500 performance restricted stock units tied to cumulative EBITDA goals in fiscal 2026. Rudow will serve as CEO through the end of fiscal 2026, then act as senior advisor through fiscal 2027 with a base salary of $1.5 million per year and no additional bonus or equity in fiscal 2027, and he is subject to non-compete and non-solicitation restrictions for 24 months after his service ends.